13F filer · CIK 1214717 ↗
Geode Capital Management, LLC
You are looking at Q3 2022. See the latest, Q2 2026 →
Reported value
$659.25B
−3.4% on the quarter before
Positions
5,029
147 new · 133 sold out
Top 10
23.2%
of the value
Est. gain
−$34.06B
on stocks held all quarter
Est. return
−5.0%
on those stocks since Q2 2022
Positions as of Sep 30, 2022, from Geode Capital Management, LLC's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 34% of the reported value, each sized by its share, colored by what the fund did with it since Q2 2022. Striped tiles are options.
Largest buys
Since Q2 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Tesla~$859.8MAdded · 1.5% → 1.9%+3,245,347 shares
- Amazon~$636.1MAdded · 2.4% → 2.7%+5,636,544 shares
- Microsoft~$585.6MAdded · 5.1% → 4.9%+2,516,899 shares
- Abbvie Inc~$502.7MAdded · 0.7% → 0.7%+3,749,074 shares
- Jacobs Solutions Inc~$272.2MNew · 0.0% → 0.0%+2,511,916 shares
- Vertex Pharmaceuticals Inc~$213.2MAdded · 0.2% → 0.2%+737,183 shares
- Apple~$207.4MAdded · 5.6% → 5.9%+1,502,326 shares
- Alphabet~$189.6MAdded · 1.8% → 1.7%+1,984,244 shares
- Merck & Co. Inc.~$181.2MAdded · 0.6% → 0.6%+2,106,251 shares
- Costar Group Inc~$179.4MAdded · 0.1% → 0.1%+2,578,917 shares
Largest sells
Since Q2 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Jacobs Solutions~$313.4MSold out · 0.0% → 0.0%−2,469,776 shares
- Home Depot Inc~$281.7MCut · 0.8% → 0.8%−1,021,963 shares
- Chevron Corp~$273.0MCut · 0.7% → 0.7%−1,901,011 shares
- American Tower~$187.8MCut · 0.4% → 0.3%−875,349 shares
- Annaly Capital Management In~$141.3MSold out · 0.0% → 0.0%−23,897,223 shares
- American Campus Communities~$135.7MSold out · 0.0% → 0.0%−2,105,148 shares
- Sailpoint Technologies Holdi~$99.7MSold out · 0.0% → 0.0%−1,590,615 shares
- Occidental Petroleum Corp~$99.3MCut · 0.1% → 0.1%−1,616,324 shares
- Healthcare Trust Of Ame-Cl A~$97.1MSold out · 0.0% → 0.0%−3,479,962 shares
- Baidu~$95.9MCut · 0.0% → 0.0%−816,583 shares
Holdings
As of Sep 30, 2022. Changes are in shares against Jun 30, 2022, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AppleCOM · shares +0.5% · price +1.2% | 5.9% | $38.62B | +$440.6M | ||||||||
| MicrosoftCOM · shares +1.8% · price −9.3% | 4.9% | $32.45B | −$3.25B | ||||||||
| AmazonCOM · shares +3.7% · price +6.5% | 2.7% | $17.79B | +$1.04B | ||||||||
| TeslaCOM · shares +7.3% · price +18.3% | 1.9% | $12.58B | +$1.81B | ||||||||
| AlphabetCAP STK CL A · shares +1.8% · price −12.2% | 1.7% | $11.00B | −$1.50B | ||||||||
| AlphabetCAP STK CL C · shares −0.8% · price −12.0% | 1.4% | $9.27B | −$1.27B | ||||||||
| Unitedhealth Group IncCOM · shares +1.7% · price −1.6% | 1.3% | $8.38B | −$134.1M | ||||||||
| Berkshire Hathaway Inc-Cl BCL B NEW · shares +0.04% · price −2.1% | 1.3% | $8.24B | −$179.4M | ||||||||
| Johnson & JohnsonCOM · shares +2.0% · price −7.9% | 1.2% | $7.78B | −$654.2M | ||||||||
| Exxon Mobil CorpCOM · shares +0.7% · price +2.0% | 0.99% | $6.51B | +$128.9M | ||||||||
| MetaCL A · shares +2.4% · price −15.8% | 0.90% | $5.92B | −$1.08B | ||||||||
| Procter & Gamble Co/TheCOM · shares +0.6% · price −12.1% | 0.88% | $5.79B | −$795.1M | ||||||||
| Visa Inc.COM CL A · shares +1.6% · price −9.7% | 0.85% | $5.61B | −$592.9M | ||||||||
| NvidiaCOM · shares +1.3% · price −19.9% | 0.83% | $5.47B | −$1.34B | ||||||||
| Jpmorgan Chase & CoCOM · shares +2.0% · price −7.1% | 0.79% | $5.24B | −$393.7M | ||||||||
| Eli LillyCOM · shares +2.4% · price −0.2% | 0.79% | $5.20B | −$10.4M | ||||||||
| Home Depot IncCOM · shares −5.3% · price +0.7% | 0.77% | $5.08B | +$34.1M | ||||||||
| Pfizer IncCOM · shares +1.7% · price −16.5% | 0.73% | $4.83B | −$936.6M | ||||||||
| Chevron CorpCOM · shares −5.4% · price −0.7% | 0.72% | $4.75B | −$32.5M | ||||||||
| MastercardCL A · shares +2.4% · price −9.8% | 0.69% | $4.57B | −$485.2M | ||||||||
| Abbvie IncCOM · shares +12% · price −12.3% | 0.69% | $4.54B | −$565.6M | ||||||||
| Coca-Cola Co/TheCOM · shares +2.8% · price −10.9% | 0.64% | $4.22B | −$501.3M | ||||||||
| Merck & Co. Inc.COM · shares +4.6% · price −5.5% | 0.63% | $4.14B | −$228.8M | ||||||||
| Pepsico IncCOM · shares +2.2% · price −2.0% | 0.63% | $4.14B | −$81.6M | ||||||||
| Costco Wholesale CorpCOM · shares +1.2% · price −1.4% | 0.58% | $3.79B | −$52.9M | ||||||||
| Total · 5,029 positions | 100% | $659.25B | −$34.06B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q2 2022 to Q3 2022: 4,879 stocks held throughout, down $34.06B (−5.0%).
- Tesla3:1 split+$1.81B+18%
- Amazon+$1.04B+6%
- Netflix+$469.3M+35%
- Apple+$440.6M+1%
- PayPal+$329.5M+23%
- Meta−$1.08B−16%
- Alphabet20:1 split−$1.27B−12%
- Nvidia−$1.34B−20%
- Alphabet20:1 split−$1.50B−12%
- Microsoft−$3.25B−9%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 16 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 12, 2026 | $1.88T+17% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $1.61T−1% | SEC ↗ |
| Q4 2025 | Feb 9, 2026 | $1.62T+3% | SEC ↗ |
| Q3 2025 | Nov 12, 2025 | $1.57T+10% | SEC ↗ |
| Q2 2025 | Aug 8, 2025 | $1.43T+12% | SEC ↗ |
| Q1 2025 | May 13, 2025 | $1.27T−1% | SEC ↗ |
| Q4 2024 | Feb 12, 2025 | $1.29T+5% | SEC ↗ |
| Q3 2024 | Nov 12, 2024 | $1.23T+8% | SEC ↗ |
| Q2 2024 | Aug 9, 2024 | $1.14T+5% | SEC ↗ |
| Q1 2024 | May 13, 2024 | $1.08T+13% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $955.85B+14% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $839.58B−1% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $850.99B+11% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $770.08B+8% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $712.57B+8% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $659.25B−3% | SEC ↗ |
| Q2 2022 | Aug 12, 2022 | $682.64B−15% | SEC ↗ |
| Q1 2022 | May 13, 2022 | $801.12B−4% | SEC ↗ |
| Q4 2021 | Feb 11, 2022 | $830.26B+12% | SEC ↗ |
| Q3 2021 | Nov 12, 2021 | $742.82B+2% | SEC ↗ |
| Q2 2021 | Aug 13, 2021 | $725.80B+11% | SEC ↗ |
| Q1 2021 | May 12, 2021 | $653.80B+10% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $595.80B+17% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $510.36B+9% | SEC ↗ |
| Q2 2020 | Aug 13, 2020 | $467.44B+22% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $383.70B−60% | SEC ↗ |
| Q4 2019 | Feb 13, 2020 (amended) | $956.78B+123% | SEC ↗ |
| Q3 2019 | Nov 12, 2019 | $428.50B+4% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $413.26B+7% | SEC ↗ |
| Q1 2019 | May 14, 2019 | $385.96B−40% | SEC ↗ |
| Q4 2018 | Feb 13, 2019 (amended) | $646.86B+82% | SEC ↗ |
| Q3 2018 | Nov 13, 2018 | $354.88B+9% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $325.29B+6% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $306.93B+4% | SEC ↗ |
| Q4 2017 | Feb 13, 2018 | $294.47B+9% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $270.92B+7% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $254.31B+4% | SEC ↗ |
| Q1 2017 | Jun 21, 2017 (amended) | $243.78B+13% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $215.04B+8% | SEC ↗ |
| Q3 2016 | Nov 10, 2016 | $198.58B+8% | SEC ↗ |
| Q2 2016 | Aug 12, 2016 | $183.87B−2% | SEC ↗ |
| Q1 2016 | May 13, 2016 | $188.44B | SEC ↗ |